A Study of LY2599666 in Healthy Participants and Participants With Mild Cognitive Impairment or Alzheimer's Disease (AD)

Clinical trial NCT02614131 · TERMINATED

Trial details

NCT number: NCT02614131
Sponsor: Eli Lilly and Company
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Alzheimer's Disease Mild Cognitive Impairment

Start date: 2015-12-01
Primary completion: 2016-12-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.